Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Search

Page Path
HOME > Search
7 "Mass screening"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Reviews
Revision of Quality Indicators for the Endoscopy Quality Improvement Program of the National Cancer Screening Program in Korea
Jun Ki Min, Jae Myung Cha, Yu Kyung Cho, Jie-Hyun Kim, Soon Man Yoon, Jong Pil Im, Yunho Jung, Jeong Seop Moon, Jin-Oh Kim, Yoon Tae Jeen
Clin Endosc 2018;51(3):239-252.   Published online May 31, 2018
DOI: https://doi.org/10.5946/ce.2018.075
AbstractAbstract PDFPubReaderePub
Gastroscopy and colonoscopy are widely used for the early diagnosis of stomach and colorectal cancer. The present revision integrates recent data regarding previous quality indicators and novel indicators suggested for gastroscopy and colonoscopy procedures for the National Cancer Screening Program in Korea. The new indicators, developed by the Quality Improvement Committee of the Korean Society for Gastrointestinal Endoscopy, vary in the level of supporting evidence, and most are based solely on expert opinion. Updated indicators validated by clinical research were prioritized, but were chosen by expert consensus when such studies were absent. The resultant quality indicators were graded according to the levels of consensus and recommendations. The updated indicators will provide a relevant guideline for high-quality endoscopy. The future direction of quality indicator development should include relevant outcome measures and an evidence-based approach to support proposed performance targets.

Citations

Citations to this article as recorded by  
  • GastroHUN an Endoscopy Dataset of Complete Systematic Screening Protocol for the Stomach
    Diego Bravo, Juan Frias, Felipe Vera, Juan Trejos, Carlos Martínez, Martín Gómez, Fabio González, Eduardo Romero
    Scientific Data.2025;[Epub]     CrossRef
  • Association of Intensive Endoscopic Burden with Esophageal Cancer Detection: A Nationwide Cohort Study
    Yeunji Lee, Eunyoung Lee, Bumhee Park, Gil Ho Lee, Sun Gyo Lim, Sung Jae Shin, Choong-Kyun Noh, Kee Myung Lee
    Gut and Liver.2025; 19(1): 59.     CrossRef
  • Current status of quality control in screening esophagogastroduodenoscopy and the emerging role of artificial intelligence
    Lihui Zhang, Liwen Yao, Zihua Lu, Honggang Yu
    Digestive Endoscopy.2024; 36(1): 5.     CrossRef
  • Performance of the National Cancer Screening Program for Gastric Cancer in Korea
    Young-Il Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2024; 24(3): 231.     CrossRef
  • Association between Endoscopist Volume and Interval Cancers after Colonoscopy: Results from the National Colorectal Cancer Screening Program in Korea
    Dong Jun Kim, Nan-He Yoon, Jae Kwan Jun, Mina Suh, Sunhwa Lee, Seongju Kim, Ji Eun Kim, Hooyeon Lee
    Cancer Research and Treatment.2024; 56(4): 1164.     CrossRef
  • Interval Advanced Gastric Cancer After Negative Endoscopy
    Tae Jun Kim, Jeung Hui Pyo, Young Hye Byun, Sung Chul Choi, Jin Pyo Hong, Yang Won Min, Hyuk Lee, Byung-Hoon Min, Poong-Lyul Rhee, Jae J. Kim, Jun Haeng Lee
    Clinical Gastroenterology and Hepatology.2023; 21(5): 1205.     CrossRef
  • Simulator-based training method in gastrointestinal endoscopy training and currently available simulators
    Yuri Kim, Jeong Hoon Lee, Gin Hyug Lee, Ga Hee Kim, Gunn Huh, Seung Wook Hong, Hwoon-Yong Jung
    Clinical Endoscopy.2023; 56(1): 1.     CrossRef
  • Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition
    Su Young Kim, Min Seob Kwak, Soon Man Yoon, Yunho Jung, Jong Wook Kim, Sun-Jin Boo, Eun Hye Oh, Seong Ran Jeon, Seung-Joo Nam, Seon-Young Park, Soo-Kyung Park, Jaeyoung Chun, Dong Hoon Baek, Mi-Young Choi, Suyeon Park, Jeong-Sik Byeon, Hyung Kil Kim, Joo
    Intestinal Research.2023; 21(1): 20.     CrossRef
  • Quality indicators in the endoscopic detection of gastric cancer
    Vikneswaran Namasivayam, Noriya Uedo
    DEN Open.2023;[Epub]     CrossRef
  • The Influence of Face Shields on the Quality of Colonoscopy in the Era of the COVID-19 Pandemic
    Jin Wook Lee, Hyo Jeong Lee, Dae Sung Kim, Jiyoung Yoon, Seung Wook Hong, Ha Won Hwang, Jong-Soo Lee, Gwang-Un Kim, Sinwon Lee, Jaewon Choe, Jin Hwa Park, Dong-Hoon Yang, Jeong-Sik Byeon
    Gut and Liver.2022; 16(3): 404.     CrossRef
  • Quality indicators in esophagogastroduodenoscopy
    Sang Yoon Kim, Jae Myung Park
    Clinical Endoscopy.2022; 55(3): 319.     CrossRef
  • Utilization and quality assessment of digestive endoscopy in China: results from 5-year consecutive nationwide surveys
    Lei Xin, Ye Gao, Zhiyuan Cheng, Tianjiao Wang, Han Lin, Yanan Pang, Chang Sun, Zengjun Fu, Zhaoshen Li, Xudong Ma, Luowei Wang
    Chinese Medical Journal.2022;[Epub]     CrossRef
  • Reduced detection rate of artificial intelligence in images obtained from untrained endoscope models and improvement using domain adaptation algorithm
    Junseok Park, Youngbae Hwang, Hyun Gun Kim, Joon Seong Lee, Jin-Oh Kim, Tae Hee Lee, Seong Ran Jeon, Su Jin Hong, Bong Min Ko, Seokmin Kim
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • A scoping review on population-centered indicators for cancer care continuum
    Vasuki Rajaguru, Jieun Jang, Jeoung A. Kwon, Jae Hyun Kim, Jaeyong Shin, Mison Chun
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 Revised Edition
    Su Young Kim, Min Seob Kwak, Soon Man Yoon, Yunho Jung, Jong Wook Kim, Sun-Jin Boo, Eun Hye Oh, Seong Ran Jeon, Seung-Joo Nam, Seon-Young Park, Soo-Kyung Park, Jaeyoung Chun, Dong Hoon Baek, Mi-Young Choi, Suyeon Park, Jeong-Sik Byeon, Hyung Kil Kim, Joo
    The Korean Journal of Gastroenterology.2022; 80(3): 115.     CrossRef
  • Antispasmodic Agent Administration Improves Gastric Neoplasm Detection Rates during Esophagogastroduodenoscopy
    Sang Yoon Kim, Jae Myung Park
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(3): 246.     CrossRef
  • Korean guidelines for postpolypectomy colonoscopic surveillance: 2022 revised edition
    Su Young Kim, Min Seob Kwak, Soon Man Yoon, Yunho Jung, Jong Wook Kim, Sun-Jin Boo, Eun Hye Oh, Seong Ran Jeon, Seung-Joo Nam, Seon-Young Park, Soo-Kyung Park, Jaeyoung Chun, Dong Hoon Baek, Mi-Young Choi, Suyeon Park, Jeong-Sik Byeon, Hyung Kil Kim, Joo
    Clinical Endoscopy.2022; 55(6): 703.     CrossRef
  • Current Endoscopy Training in Korea and Future Aspects
    Young-Eun Joo
    The Korean Journal of Gastroenterology.2022; 80(5): 207.     CrossRef
  • Colonoscopy quality in community hospitals and nonhospital facilities in Korea
    Jae Gon Lee, Dong Soo Han, Young-Eun Joo, Dae-Seong Myung, Dong Il Park, Seul Ki Kim, Yunho Jung, Won Hyun Lee, Eun Soo Kim, Joon Seok Yoon, Chang Soo Eun
    The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S35.     CrossRef
  • Association of Regular Endoscopic Screening with Interval Gastric Cancer Incidence in the National Cancer Screening Program
    Choong-Kyun Noh, Eunyoung Lee, Gil Ho Lee, Sun Gyo Lim, Bumhee Park, Sung Jae Shin, Jae Youn Cheong, Kee Myung Lee
    Journal of Clinical Medicine.2021; 11(1): 230.     CrossRef
  • Impacts of age and sedation on cardiocerebrovascular adverse events after diagnostic GI endoscopy: a nationwide population-based study
    Sang Yoon Kim, Chang Mo Moon, Min Ho Kim, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim, Sung-Ae Jung
    Gastrointestinal Endoscopy.2020; 92(3): 591.     CrossRef
  • Efficacy and Patient Tolerability Profiles of Probiotic Solution with Bisacodyl Versus Conventional Cleansing Solution for Bowel Preparation: A Prospective, Randomized, Controlled Trial
    Youn I Choi, Jong-Joon Lee, Jun-Won Chung, Kyoung Oh Kim, Yoon Jae Kim, Jung Ho Kim, Dong Kyun Park, Kwang An Kwon
    Journal of Clinical Medicine.2020; 9(10): 3286.     CrossRef
  • Endoscopy training in Korea
    Joon Sung Kim, Byung-Wook Kim
    The Korean Journal of Internal Medicine.2019; 34(2): 237.     CrossRef
  • Updates on the Facilities, Procedures, and Performance of the Accredited Endoscopy Unit
    Tae Hee Lee, Jin Young Yoon, Chang Nyol Paik, Hyuk Soon Choi, Jae-Young Jang
    Clinical Endoscopy.2019; 52(5): 431.     CrossRef
  • Quality Indicators and Outcome Measures of Endoscopy in the National Cancer Screening Program
    Jun Ki Min, Jae Myung Cha, Min Seob Kwak, Jin Young Yoon, Yunho Jung, Jeong Eun Shin, Hyo-Joon Yang
    Yonsei Medical Journal.2019; 60(11): 1054.     CrossRef
  • 7,490 View
  • 191 Download
  • 24 Web of Science
  • 25 Crossref
Close layer
How to Improve the Quality of Screening Endoscopy in Korea: National Endoscopy Quality Improvement Program
Yu Kyung Cho
Clin Endosc 2016;49(4):312-317.   Published online July 29, 2016
DOI: https://doi.org/10.5946/ce.2016.084
AbstractAbstract PDFPubReaderePub
In Korea, gastric cancer screening, either esophagogastroduodenoscopy or upper gastrointestinal series (UGIS), is performed biennially for adults aged 40 years or older. Screening endoscopy has been shown to be associated with localized cancer detection and better than UGIS. However, the diagnostic sensitivity of detecting cancer is not satisfactory. The National Endoscopy Quality Improvement (QI) program was initiated in 2009 to enhance the quality of medical institutions and improve the effectiveness of the National Cancer Screening Program (NCSP). The Korean Society of Gastrointestinal Endoscopy developed quality standards through a broad systematic review of other endoscopic quality guidelines and discussions with experts. The standards comprise five domains: qualifications of endoscopists, endoscopic unit facilities and equipment, endoscopic procedure, endoscopy outcomes, and endoscopic reprocessing. After 5 years of the QI program, feedback surveys showed that the perception of QI and endoscopic practice improved substantially in all domains of quality, but the quality standards need to be revised. How to avoid missing cancer in endoscopic procedures in daily practice was reviewed, which can be applied to the mass screening endoscopy. To improve the quality and effectiveness of NCSP, key performance indicators, acceptable quality standards, regular audit, and appropriate reimbursement are necessary.

Citations

Citations to this article as recorded by  
  • Simethicone and N-acetyl cysteine combination as premedication before esophagogastroduodenoscopy: Double-blind randomized controlled trial
    Veeraraghavan Krishnamurthy, Abel Joseph, Shreyas Venkataraman, George Kurian
    Endoscopy International Open.2022; 10(05): E585.     CrossRef
  • Trends in the Performance of the Korean National Cancer Screening Program for Gastric Cancer from 2007 to 2016
    Ji Eun Ryu, Eunji Choi, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu Won Jung, Kui Son Choi
    Cancer Research and Treatment.2022; 54(3): 842.     CrossRef
  • Current Endoscopy Training in Korea and Future Aspects
    Young-Eun Joo
    The Korean Journal of Gastroenterology.2022; 80(5): 207.     CrossRef
  • Clinical features of gastric adenoma detected within 3 years after negative screening endoscopy in Korea
    Hyun Young Kim
    Gastroenterology Report.2022;[Epub]     CrossRef
  • Response
    Sang Yoon Kim, Jae Myung Park
    Gastrointestinal Endoscopy.2021; 94(4): 876.     CrossRef
  • A Nationwide Survey on the Facilities and Personnel for Endoscopic Sedation: Results from 50 Qualified Endoscopy Units of Teaching Hospitals Accredited by the Korean Society of Gastrointestinal Endoscopy (KSGE)
    Seon-Young Park, Jun Kyu Lee, Jung-Wook Kim, Tae Hee Lee, Chang-Hwan Park, Jae-Yong Jang, Byung-Wook Kim, Byung Ik Jang
    Clinical Endoscopy.2021; 54(6): 843.     CrossRef
  • Screening for gastric cancer: East and West, features of diagnostic criteria
    A. A. Avanesyan, O. V. Chukina, Yu. V. Kokovina, T. M. Chirkina, I. G. Bakulin
    Experimental and Clinical Gastroenterology.2020; (9): 73.     CrossRef
  • Endoscopy training in Korea
    Joon Sung Kim, Byung-Wook Kim
    The Korean Journal of Internal Medicine.2019; 34(2): 237.     CrossRef
  • Establishing a model to measure and predict the quality of gastrointestinal endoscopy
    Luo-Wei Wang, Han Lin, Lei Xin, Wei Qian, Tian-Jiao Wang, Jian-Zhong Zhang, Qian-Qian Meng, Bo Tian, Xu-Dong Ma, Zhao-Shen Li
    World Journal of Gastroenterology.2019; 25(8): 1024.     CrossRef
  • Factors related to paradoxical reactions during propofol-induced sedated endoscopy
    Seung Hwa Lee, Gyu Min Lee, Dong Ryul Lee, Jung Un Lee
    Scandinavian Journal of Gastroenterology.2019; 54(3): 371.     CrossRef
  • Laparoscopic Surgery for Gastric Cancer: The European Point of View
    Mickael Chevallay, Minoa Jung, Felix Berlth, Chon Seung-Hun, Philippe Morel, Stefan Mönig
    Journal of Oncology.2019; 2019: 1.     CrossRef
  • Quality Indicators and Outcome Measures of Endoscopy in the National Cancer Screening Program
    Jun Ki Min, Jae Myung Cha, Min Seob Kwak, Jin Young Yoon, Yunho Jung, Jeong Eun Shin, Hyo-Joon Yang
    Yonsei Medical Journal.2019; 60(11): 1054.     CrossRef
  • Needs assessment survey for simulation‐based training for gastrointestinal endoscopy nurses
    Sol Yu, Young Sook Roh
    Nursing & Health Sciences.2018; 20(2): 247.     CrossRef
  • Screening for gastric cancer with magnetically controlled capsule gastroscopy in asymptomatic individuals
    An-Jing Zhao, Yang-Yang Qian, Hui Sun, Xi Hou, Jun Pan, Xiao Liu, Wei Zhou, Yi-Zhi Chen, Xi Jiang, Zhao-Shen Li, Zhuan Liao
    Gastrointestinal Endoscopy.2018; 88(3): 466.     CrossRef
  • Gastrointestinal endoscopy satisfaction questionnaire is a valid tool to measure patient satisfaction in Asian country
    Jin Young Yoon, Jae Myung Cha, Min Seob Kwak, Jung Won Jeon, Hyun Phil Shin, Kwang Ro Joo, Joung Il Lee
    Medicine.2018; 97(29): e11477.     CrossRef
  • An Adjusted Level of Adenoma Detection Rate is Necessary for Adults Below 50 Years Old
    Jin Young Yoon, Jae Myung Cha, Jeong Eun Shin, Kyeong Ok Kim, Hyo-Joon Yang, Hyun Gun Kim, Young-Seok Cho, Sun-Jin Boo, Jun Lee, Yunho Jung, Hyun Jung Lee, Hoon Sup Koo, Young-Eun Joo
    Journal of Clinical Gastroenterology.2018; 52(8): 703.     CrossRef
  • Trends in Gastric Cancer Incidence According to the Clinicopathological Characteristics in Korea, 1999-2014
    Bang Wool Eom, Kyu-Won Jung, Young-Joo Won, Hannah Yang, Young-Woo Kim
    Cancer Research and Treatment.2018; 50(4): 1343.     CrossRef
  • Training in Endoscopy: Esophagogastroduodenoscopy
    Joon Sung Kim, Byung-Wook Kim
    Clinical Endoscopy.2017; 50(4): 318.     CrossRef
  • Does the interval of screening endoscopy affect survival in gastric cancer patients?
    Jieun Kim, Su Mi Kim, Man Ho Ha, Jeong Eun Seo, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Sin-Ho Jung, Jae Moon Bae
    Medicine.2016; 95(49): e5490.     CrossRef
  • 9,506 View
  • 212 Download
  • 19 Web of Science
  • 19 Crossref
Close layer
Original Article
Feedback Survey of the Effect, Burden, and Cost of the National Endoscopic Quality Assessment Program during the Past 5 Years in Korea
Yu Kyung Cho, Jeong Seop Moon, Dong Su Han, Yong Chan Lee, Yeol Kim, Bo Young Park, Il-Kwun Chung, Jin-Oh Kim, Jong Pil Im, Jae Myung Cha, Hyun Gun Kim, Sang Kil Lee, Hang Lak Lee, Jae Young Jang, Eun Sun Kim, Yunho Jung, Chang Mo Moon, Ethics and Quality Control Committee of Korean Society of Gastrointestinal Endoscopy
Clin Endosc 2016;49(6):542-547.   Published online March 2, 2016
DOI: https://doi.org/10.5946/ce.2015.113
AbstractAbstract PDFPubReaderePub
Background
/Aims: In Korea, the nationwide gastric cancer screening program recommends biennial screening for individuals aged 40 years or older by way of either an upper gastrointestinal series or endoscopy. The national endoscopic quality assessment (QA) program began recommending endoscopy in medical institutions in 2009. We aimed to assess the effect, burden, and cost of the QA program from the viewpoint of medical institutions.
Methods
We surveyed the staff of institutional endoscopic units via e-mail.
Results
Staff members from 67 institutions replied. Most doctors were endoscopic specialists. They responded as to whether the QA program raised awareness for endoscopic quality (93%) or improved endoscopic practice (40%). The percentages of responders who reported improvements in the diagnosis of gastric cancer, the qualifications of endoscopists, the quality of facilities and equipment, endoscopic procedure, and endoscopic reprocessing were 69%, 60%, 66%, 82%, and 75%, respectively. Regarding reprocessing, many staff members reported that they had bought new automated endoscopic preprocessors (3%), used more disinfectants (34%), washed endoscopes longer (28%), reduced the number of endoscopies performed to adhere to reprocessing guidelines (9%), and created their own quality education programs (59%). Many responders said they felt that QA was associated with some degree of burden (48%), especially financial burden caused by purchasing new equipment. Reasonable quality standards (45%) and incentives (38%) were considered important to the success of the QA program.
Conclusions
Endoscopic quality has improved after 5 years of the mandatory endoscopic QA program.

Citations

Citations to this article as recorded by  
  • Monthly endoscopy surveillance culture facilitates detection of breaches in the scope reprocessing procedure: 5‐year experience in an endoscopy center
    Shu‐Hui Chen, Theophile Liu, Huei‐Wen Lai, Hui‐Lan Chang, Hsu‐Heng Yen
    Advances in Digestive Medicine.2022; 9(2): 103.     CrossRef
  • A nationwide survey on the effectiveness of training on endoscope reprocessing within the national cancer screening program in Korea
    Hye Young Shin, Da Hun Jang, Jae Kwan Jun
    American Journal of Infection Control.2021; 49(8): 1031.     CrossRef
  • Polyp missing rate and its associated risk factors of referring hospitals for endoscopic resection of advanced colorectal neoplasia
    Jae Gyu Shin, Hyung Wook Kim, Su Bum Park, Cheol Woong Choi, Dae Hwan Kang, Su Jin Kim, Hyeong Seok Nam, Dae Gon Ryu
    Medicine.2017; 96(19): e6742.     CrossRef
  • Education and Training Guidelines for the Board of the Korean Society of Gastrointestinal Endoscopy
    Hee Seok Moon, Eun Kwang Choi, Ji Hyun Seo, Jeong Seop Moon, Ho June Song, Kyoung Oh Kim, Jong Jin Hyun, Sung Kwan Shin, Beom Jae Lee, Sang Heon Lee
    Clinical Endoscopy.2017; 50(4): 345.     CrossRef
  • How to Improve the Quality of Screening Endoscopy in Korea: National Endoscopy Quality Improvement Program
    Yu Kyung Cho
    Clinical Endoscopy.2016; 49(4): 312.     CrossRef
  • How Can We Propagate the National Endoscopy Quality Improvement Program and Improve the Quality of Endoscopic Screening?
    Dong-Hoon Yang
    Gut and Liver.2016; 10(5): 657.     CrossRef
  • The Importance of an Endoscopic Quality Assessment Program Reflecting Real Practice
    In Kyung Yoo, Yoon Tae Jeen
    Clinical Endoscopy.2016; 49(6): 495.     CrossRef
  • 10,532 View
  • 138 Download
  • 5 Web of Science
  • 7 Crossref
Close layer
Focused Review Series: Endoscopic Screening and Surveillance for Gastrointestinal Cancer
Prevention Strategies for Gastric Cancer: A Global Perspective
Jin Young Park, Lawrence von Karsa, Rolando Herrero
Clin Endosc 2014;47(6):478-489.   Published online November 30, 2014
DOI: https://doi.org/10.5946/ce.2014.47.6.478
AbstractAbstract PDFPubReaderePub

Despite the substantial burden of gastric cancer worldwide, population strategies for primary prevention have not been introduced in any country. Recognizing the causal role of Helicobacter pylori infection, there is increasing interest in population-based programs to eradicate the infection to prevent gastric cancer. Nonetheless, the paucity of available evidence on feasibility and effectiveness has prevented implementation of this approach. There are very few secondary prevention programs based on screening with endoscopy or radiography, notably in the Republic of Korea and Japan, two of the countries with the highest incidence rates of gastric cancer. In Korea, where the organized screening program is in place, survival rate of gastric cancer is as high as 67%. More research is needed to quantify the specific contribution of the screening program to observed declines in mortality rates. Gastric cancer screening is unlikely to be feasible in many Low-Middle Income Countries where the gastric cancer burden is high. Prevention strategies are still under development and the optimal approach may differ depending on local conditions and societal values. The present review gives an overview of the etiology and burden of the disease, and possible prevention strategies for countries and regions confronted with a significant burden of disease.

Citations

Citations to this article as recorded by  
  • Birth cohort and age-specific trends in global Helicobacter pylori seroprevalence: a scoping review
    Chelsea S. Taylor, Mercedes V. McMahon, Zachary J. Ward, Fernando Alarid-Escudero, M. Constanza Camargo, Monika Laszkowska, Jorge Roa, Jennifer M. Yeh
    The Lancet Regional Health - Americas.2025; 41: 100877.     CrossRef
  • A meta-analysis of randomized controlled trials examining the efficacy and safety of elemene in combination with chemotherapy for the treatment of gastric cancer
    Yige Liu, Feng Du, Bo Chen, Sanjay Rastogi, Yanhua Huang
    EXPLORE.2025; 21(1): 103076.     CrossRef
  • Targeting ferroptosis in gastrointestinal tumors: Interplay of iron-dependent cell death and autophagy
    Mohamad Hosein Safari, Payman Rahimzadeh, Elmira Alaei, Mina Alimohammadi, Negin Esfandiari, Salman Daneshi, Neda Malgard, Najma Farahani, Afshin Taheriazam, Mehrdad Hashemi
    Molecular and Cellular Probes.2025; 79: 102013.     CrossRef
  • Comprehensive assessment of serum 3′-tRFArg as a novel diagnostic biomarker for gastric cancer
    Rui Ding, Yang Li, Yu Zhang, Xun Li, Yunjian Song, Xinliang Gu, Xianjuan Shen, Shaoqing Ju
    Translational Oncology.2025; 54: 102338.     CrossRef
  • The clinical presentation and outcome of gastric cancer
    Ayad Ahmad Mohammed, Mohammed Rasheed Mohammed, Rezvan Faisal Abduljabbar
    International Journal of Surgery: Global Health.2025;[Epub]     CrossRef
  • Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990–2019: An Examination of Global Burden of Disease 2019
    Rajesh Sharma
    Journal of Gastrointestinal Cancer.2024; 55(2): 787.     CrossRef
  • S-1 plus oxaloplatin (S-1OX) versus capecitabine plus oxaloplatin (CAPOX) for advanced gastric cancer: A systematic review and meta-analysis
    S.M.Zeeshan Qadar, Zhiyong Dong, Sheikh Mohammed Shariful Islam, Jianxue Wang, Xiling Xu, Fakhsheena Anjum, Sana Shamim, Bafreen Sherif, Sundas Ali
    Computer Methods and Programs in Biomedicine Update.2024; 5: 100151.     CrossRef
  • Gastric Cancer: A Comprehensive Literature Review
    Reda H Mithany, M Hasaan Shahid, Mina Manasseh, Muhammad Talha Saeed, Samana Aslam, Mohamed S Mohamed, Nesma Daniel
    Cureus.2024;[Epub]     CrossRef
  • Circulating long noncoding RNA, Zfpm2-As1, and XIST based on medical data analysis are potential plasma biomarkers for gastric cancer diagnosis
    Han Liang, Hao Li, Nan Xia, Jingjing Chen, Linlin Gao, Hao Liu, Ping Lyu, Xiaolin Guo, Ziwei Yang, Chi Lin, Chang Wu Yu, Ning Wang
    Technology and Health Care.2024; 32(6): 4919.     CrossRef
  • Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer
    Marek Mazurek, Monika Szewc, Monika Z. Sitarz, Ewa Dudzińska, Robert Sitarz
    Cancers.2024; 16(18): 3163.     CrossRef
  • Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study
    Xiaokun Zhao, Na Ding
    Scientific Reports.2024;[Epub]     CrossRef
  • PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS
    Zhandong Zhang, Liangqun Peng, Wei Yang, Baodong Li, Yawei Hua, Suxia Luo
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness—A Practical Preventing Recommendation and Therapies
    Edoardo Tacconi, Giuseppe Palma, Davide De Biase, Antonio Luciano, Massimiliano Barbieri, Filomena de Nigris, Francesca Bruzzese
    Nutrients.2023; 15(3): 563.     CrossRef
  • Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer
    Lei Ren, Hong Deng, Yu Jiang, Chunfeng Liu
    Digestive Diseases and Sciences.2023; 68(4): 1292.     CrossRef
  • Investigation of The Antiproliferative Effect of Colchicine on SNU-1 Gastric Cancer Cells
    Fatih Yulak
    Cumhuriyet Science Journal.2023; 44(2): 263.     CrossRef
  • Incidence and Patterns of Digestive Organ Cancer in Georgia: Insights from a Population-Based Registry Study in 2021
    Miranda Nonikashvili, Maia Kereselidze, Otar Toidze, Tina Beruchashvili
    Journal of Personalized Medicine.2023; 13(7): 1121.     CrossRef
  • Role of microorganisms in the developmental, prognostic, and therapeutics of gastric cancer
    Sadaf Wajahat
    Iranian Journal of Blood and Cancer.2023; 15(4): 272.     CrossRef
  • M-CSF secreted by gastric cancer cells exacerbates the progression of gastric cancer by increasing the expression of SHP2 in tumor-associated macrophages
    Shaohua Zhang, Dongfei Ren, Huiyu Hou, Li Yao, Hufang Yuan
    Aging.2023; 15(24): 15525.     CrossRef
  • Sijunzi Decoction Inhibits Stemness by Suppressing β-Catenin Transcriptional Activity in Gastric Cancer Cells
    Yue-jun Li, Lin-li Liao, Pei Liu, Ping Tang, Hong Wang, Qing-hua Peng
    Chinese Journal of Integrative Medicine.2022; 28(8): 702.     CrossRef
  • The Effect of Palliative Invasive Interventions on Overall Survival in the Last 3 Months of Life in Metastatic Gastric Cancer
    Ferhat Ekinci, Atike Pınar Erdoğan
    Journal of Gastrointestinal Cancer.2022; 53(2): 496.     CrossRef
  • Prediction Models for Gastric Cancer Risk in the General Population: A Systematic Review
    Jianhua Gu, Ru Chen, Shao-Ming Wang, Minjuan Li, Zhiyuan Fan, Xinqing Li, Jiachen Zhou, Kexin Sun, Wenqiang Wei
    Cancer Prevention Research.2022; 15(5): 309.     CrossRef
  • Prevalence of Helicobacter pylori in Non-Cardia Gastric Cancer in China: A Systematic Review and Meta-Analysis
    Yong Lu, Fei Xiao, Yuan Wang, Zhenyu Wang, Di Liu, Feng Hong
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancer
    Yu Zhang, Xinliang Gu, Xinyue Qin, Yuejiao Huang, Shaoqing Ju
    Molecular Medicine.2022;[Epub]     CrossRef
  • Molecular and Circulating Biomarkers of Gastric Cancer
    Wojciech Jelski, Barbara Mroczko
    International Journal of Molecular Sciences.2022; 23(14): 7588.     CrossRef
  • Diagnostic value of long noncoding RNA LINC01060 in gastric cancer
    Junhui Huang, Junrong Wu, Zuojian Hu, Cuiju Mo, Huaping Chen, Liuyi Lu, Mingxing Chen, Xiamei Huang, Xue Qin
    Journal of Laboratory Medicine.2022; 46(5): 361.     CrossRef
  • Nadir Görülen Malign Mide Tümörlerinde Cerrahi Tedavi Sonuçlarımız
    Ramazan GÜNDOĞDU, Hakan YABANOĞLU, Serkan ERKAN, Murat KUŞ
    Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi.2022; 9(2): 137.     CrossRef
  • Global burden of major gastrointestinal cancers and its association with socioeconomics, 1990–2019
    Mei-Zhu Hong, Jing-Mao Li, Zhi-Jian Chen, Xiao-Yun Lin, Jin-Shui Pan, Li-Li Gong
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • GCdiscrimination: identification of gastric cancer based on a milliliter of blood
    Jiangpeng Wu, Yifan Yang, Long Cheng, Jing Wu, Lili Xi, Ying Ma, Pengyi Zhang, Xiaoying Xu, Dekui Zhang, Shuyan Li
    Briefings in Bioinformatics.2021; 22(1): 536.     CrossRef
  • Association of Helicobacter pylori Infection and Host Cytokine Gene Polymorphism with Gastric Cancer
    Md. Zeyaullah, Abdullah M. AlShahrani, Irfan Ahmad, Giovanni Marasco
    Canadian Journal of Gastroenterology and Hepatology.2021; 2021: 1.     CrossRef
  • Silencing lncRNA XIST exhibits antiproliferative and proapoptotic effects on gastric cancer cells by up-regulating microRNA-132 and down-regulating PXN
    Ping Li, Liuhua Wang, Pengfei Li, Fangyong Hu, Yi Cao, Dong Tang, Gang Ye, Hongbo Li, Daorong Wang
    Aging.2021; 13(10): 14469.     CrossRef
  • Knockdown of PYCR1 suppressed the malignant phenotype of human hepatocellular carcinoma cells via inhibiting the AKT pathway activation
    Jiang Guo, Xiaoyan Cheng, Yanjie Tian, Baoming Li, Xiaoli Zhang, Xuesong Gao, Yunhe An
    Reproductive Biology.2021; 21(3): 100534.     CrossRef
  • Identification and epidemiological evaluation of gastric cancer risk factors: based on a field synopsis and meta-analysis in Chinese population
    Fujiao Duan, Chunhua Song, Jiachen Shi, Peng Wang, Hua Ye, Liping Dai, Jianying Zhang, Kaijuan Wang
    Aging.2021; 13(17): 21451.     CrossRef
  • Evaluation of the Methylation of MIR129-2 Gene in Gastric Cancer
    Nazila Alizadeh, Milad Asadi, Dariush Shanehbandi, Venus Zafari, Navid Shomali, Touraj Asvadi, Bita Sepehri
    Journal of Gastrointestinal Cancer.2020; 51(1): 267.     CrossRef
  • miR‐449c‐5p availability is antagonized by circ‐NOTCH1 for MYC‐induced NOTCH1 upregulation as well as tumor metastasis and stemness in gastric cancer
    Xiaoyong Zhao, Qinggui Zhong, Xueyan Cheng, Shang Wang, Ruiqing Wu, Xinling Leng, Lei Shao
    Journal of Cellular Biochemistry.2020; 121(10): 4052.     CrossRef
  • Human adipose-derived mesenchymal stem cells inhibit proliferation and induce apoptosis of human gastric cancer HGC-27 cells
    Jianhong Zhao, Zilong Zhang, Qingfeng Cui, Lina Zhao, Yongjun Hu, Subin Zhao
    3 Biotech.2020;[Epub]     CrossRef
  • Exosomal Long Non-Coding RNA CEBPA-AS1 Inhibits Tumor Apoptosis and Functions as a Non-Invasive Biomarker for Diagnosis of Gastric Cancer


    Hai-yan Piao, Shuai Guo, Yue Wang, Jun Zhang
    OncoTargets and Therapy.2020; Volume 13: 1365.     CrossRef
  • Plasma Exosomal Long Noncoding RNA lnc-SLC2A12-10:1 as a Novel Diagnostic Biomarker for Gastric Cancer


    Peiming Zheng, Haoliang Zhang, Huijie Gao, Jingfang Sun, Junmeng Li, Xiulei Zhang, Lan Gao, Ping Ma, Shibao Li
    OncoTargets and Therapy.2020; Volume 13: 4009.     CrossRef
  • Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies
    Julita Machlowska, Jacek Baj, Monika Sitarz, Ryszard Maciejewski, Robert Sitarz
    International Journal of Molecular Sciences.2020; 21(11): 4012.     CrossRef
  • Mining topoisomerase isoforms in gastric cancer
    Guoxin Hou, Jingjing Deng, Xin You, Jing Chen, Yiming Jiang, Tingting Qian, Yanyu Bi, Binbin Song, Yufen Xu, Xinmei Yang
    Gene.2020; 754: 144859.     CrossRef
  • Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer
    Hui Zhou, Weifeng Shen, Hongxing Zou, Qingshan Lv, Pingyang Shao
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions
    Juan Liu, Shaoxian Wu, Xiao Zheng, Panpan Zheng, Yuanyuan Fu, Changping Wu, Binfeng Lu, Jingfang Ju, Jingting Jiang
    Scientific Reports.2020;[Epub]     CrossRef
  • Comparison of prognostic factors in different age groups and prognostic significance of neutrophil-lymphocyte ratio in patients with gastric cancer
    Qiong Li, Lin-Yi Huang, Hui-Ping Xue
    World Journal of Gastrointestinal Oncology.2020; 12(10): 1146.     CrossRef
  • Gastric cancer: factors affecting survival
    Suleyman Orman, Haci Murat Cayci
    Acta Chirurgica Belgica.2019; 119(1): 24.     CrossRef
  • Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area
    Boldbaatar Gantuya, Khasag Oyuntsetseg, Dashdorj Bolor, Yansan Erdene-Ochir, Ruvjir Sanduijav, Duger Davaadorj, Tegshee Tserentogtokh, Tomohisa Uchida, Yoshio Yamaoka
    Gastric Cancer.2019; 22(1): 104.     CrossRef
  • Hsa_circ_0000467 promotes cancer progression and serves as a diagnostic and prognostic biomarker for gastric cancer
    Jun Lu, Peng‐yang Zhang, Jian‐wei Xie, Jia‐bin Wang, Jian‐xian Lin, Qi‐yue Chen, Long‐long Cao, Chang‐ming Huang, Ping Li, Chao‐hui Zheng
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer
    Haidan Yan, Meifeng Li, Longlong Cao, Haifeng Chen, Hungming Lai, Qingzhou Guan, Huxing Chen, Wenbin Zhou, Baotong Zheng, Zheng Guo, Chaohui Zheng
    Journal of Translational Medicine.2019;[Epub]     CrossRef
  • The effect of Jianpi Yangzheng Xiaozheng Decoction and its components on gastric cancer
    Jian Wu, Xing-Xing Zhang, Xi Zou, Min Wang, Hong-xing Wang, Yao-hui Wang, Chang-yin Li, Lin-gang Zhao, Min Chen, Li-xia Pei, Shen-Lin Liu, Qing-Min Sun
    Journal of Ethnopharmacology.2019; 235: 56.     CrossRef
  • CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
    Jiaomeng Pan, Zhiyuan Fan, Zhenqiang Wang, Qingqiang Dai, Zhen Xiang, Fei Yuan, Min Yan, Zhenggang Zhu, Bingya Liu, Chen Li
    Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
  • Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil
    Rodrigo Santa Cruz Guindalini, Marina Cândido Visontai Cormedi, Simone Maistro, Fátima Solange Pasini, Priscila Cristina Abduch Adas Branas, Liliane dos Santos, Gláucia Fernanda de Lima Pereira, Geertruida Hendrika de Bock, Daniela Marques Saccaro, Maria
    Gastric Cancer.2019; 22(5): 920.     CrossRef
  • Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway
    Jiaomeng Pan, Qingqiang Dai, Tianqi Zhang, Chen Li
    Cancer Cell International.2019;[Epub]     CrossRef
  • Prognostic values of signal transducers activators of transcription in gastric cancer
    Yujie Zhang, Chaoran Yu
    Bioscience Reports.2019;[Epub]     CrossRef
  • Downregulation of IQGAP1 inhibits epithelial‐mesenchymal transition via the HIF1α/VEGF‐A signaling pathway in gastric cancer
    Junqiang Liu, Xiufan Ni, Yafang Li, Mengjiao Chen, Wei Chen, Ying Wu, Baoding Chen, Yan Wu, Min Xu
    Journal of Cellular Biochemistry.2019; 120(9): 15790.     CrossRef
  • Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis
    Fang Ren, Shaodan Li, Yin Zhang, Zhifei Zhao, Haiming Wang, Yixin Cui, Maoyun Wang
    Radiation Oncology.2019;[Epub]     CrossRef
  • Cáncer gástrico: una enfermedad prevenible. Estrategias para intervención en la historia natural
    Ricardo Oliveros, Raúl Eduardo Pinilla Morales, Helena Facundo Navia, Ricardo Sánchez Pedraza
    Revista Colombiana de Gastroenterología.2019; 34(2): 177.     CrossRef
  • Gastric cancer: epidemiology, biology, and prevention: a mini review
    Kiara Lyons, Linh C. Le, Yen T.-H. Pham, Claire Borron, Jong Y. Park, Chi T.D. Tran, Thuan V. Tran, Huong T.-T. Tran, Khanh T. Vu, Cuong D. Do, Claudio Pelucchi, Carlo La Vecchia, Janice Zgibor, Paolo Boffetta, Hung N. Luu
    European Journal of Cancer Prevention.2019; 28(5): 397.     CrossRef
  • Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis
    Hong Jiang, Shuai Guo, Yan Zhao, Yue Wang, Hai-yan Piao, Yue Wu, Jun Zhang
    Pathology - Research and Practice.2019; 215(10): 152569.     CrossRef
  • GLI1 activation by non-classical pathway integrin αvβ3/ERK1/2 maintains stem cell-like phenotype of multicellular aggregates in gastric cancer peritoneal metastasis
    Hui Dong, Hongchang Liu, Wen Zhou, Fan Zhang, Chuan Li, Jun Chen, Chenjun Tan, Bo Tang, Peiwu Yu
    Cell Death & Disease.2019;[Epub]     CrossRef
  • Incidence Rate of Gastric Cancer Adenocarcinoma in Patients With Gastric Dysplasia
    Maryam Akbari, Bahareh Kardeh, Reza Tabrizi, Fariba Ahmadizar, Kamran B. Lankarani
    Journal of Clinical Gastroenterology.2019; 53(10): 703.     CrossRef
  • Clinical values of circular RNA 0000181 in the screening of gastric cancer
    Qianfu Zhao, Shijun Chen, Tianwen Li, Bingxiu Xiao, Xinjun Zhang
    Journal of Clinical Laboratory Analysis.2018;[Epub]     CrossRef
  • Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells
    Youli Zhang, Dawei Wang, Meiting Zhang, Hong Wei, Ying Lu, Yaocheng Sun, Meng Zhou, Shuming Gu, Wen Feng, Huizhi Wang, Jian Zeng, Aihua Gong, Min Xu
    Experimental Cell Research.2018; 362(1): 43.     CrossRef
  • Long non-coding RNA DLEU1 predicts poor prognosis of gastric cancer and contributes to cell proliferation by epigenetically suppressing KLF2
    Xiaobin Li, Zongze Li, Ziwen Liu, Jianchun Xiao, Shuting Yu, Yimin Song
    Cancer Gene Therapy.2018; 25(3-4): 58.     CrossRef
  • Low heart rate variability relates to the progression of gastric cancer
    Songjie Hu, Jie Lou, Youping Zhang, Ping Chen
    World Journal of Surgical Oncology.2018;[Epub]     CrossRef
  • Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/β-catenin pathway
    Chengdong Ji, Lang Yang, Weijing Yi, Dongfang Xiang, Yanxia Wang, Zhihua Zhou, Feng Qian, Yong Ren, Wei Cui, Xia Zhang, Peng Zhang, Ji Ming Wang, Youhong Cui, Xiuwu Bian
    Oncogene.2018; 37(29): 3953.     CrossRef
  • Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer
    Rui Zhao, Yanli Zhang, Xin Zhang, Yongmei Yang, Xin Zheng, Xiaohui Li, Yingjie Liu, Yi Zhang
    Molecular Cancer.2018;[Epub]     CrossRef
  • The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
    Lu Gan, Midie Xu, Ruixi Hua, Cong Tan, Jieyun Zhang, Yiwei Gong, Zhenhua Wu, Weiwei Weng, Weiqi Sheng, Weijian Guo
    Journal of Hematology & Oncology.2018;[Epub]     CrossRef
  • Prediction of Overall Survival and Novel Classification of Patients with Gastric Cancer Using the Survival Recurrent Network
    Sung Eun Oh, Sung Wook Seo, Min-Gew Choi, Tae Sung Sohn, Jae Moon Bae, Sung Kim
    Annals of Surgical Oncology.2018; 25(5): 1153.     CrossRef
  • Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study
    Peter Malfertheiner, Michael Selgrad, Thomas Wex, Benedetta Romi, Erica Borgogni, Fabiana Spensieri, Luisanna Zedda, Paolo Ruggiero, Laura Pancotto, Stefano Censini, Emanuela Palla, Niranjan Kanesa-Thasan, Bruce Scharschmidt, Rino Rappuoli, David Y Graham
    The Lancet Gastroenterology & Hepatology.2018; 3(10): 698.     CrossRef
  • Self-expandable metal stents in patients with postoperative delayed gastric emptying after distal gastrectomy
    Seung Han Kim, Bora Keum, Hyuk Soon Choi, Eun Sun Kim, Yeon Seok Seo, Yoon Tae Jeen, Hong Sik Lee, Hoon Jai Chun, Soon Ho Um, Chang Duck Kim, Sungsoo Park
    World Journal of Gastroenterology.2018; 24(40): 4578.     CrossRef
  • Análise da expressão imuno-histoquímica do fator tecidual no carcinoma gástrico: correlações com prognóstico e sobrevida.
    Marcelo Garcia Toneto, Pedro Lucas Depaula, Letícia Debon, Bruna Tertuliano, Vinícius Duval Silva, Matteo Baldisseroto, André Poisl Fay, Gustavo Franco Carvalhal
    Revista do Colégio Brasileiro de Cirurgiões.2018;[Epub]     CrossRef
  • Relationship between socioeconomic status and accessibility for endoscopic resection among gastric cancer patients: using National Health Insurance Cohort in Korea: poverty and endoscopic resection
    Na Yeon Kim, Jun Seok Oh, Young Choi, Jaeyong Shin, Eun-Cheol Park
    Gastric Cancer.2017; 20(1): 61.     CrossRef
  • Helicobacter pylori gene silencing in vivo demonstrates urease is essential for chronic infection
    Aleksandra W. Debowski, Senta M. Walton, Eng-Guan Chua, Alfred Chin-Yen Tay, Tingting Liao, Binit Lamichhane, Robyn Himbeck, Keith A. Stubbs, Barry J. Marshall, Alma Fulurija, Mohammed Benghezal, Simon L. Dove
    PLOS Pathogens.2017; 13(6): e1006464.     CrossRef
  • Identifying and targeting cancer stem cells in the treatment of gastric cancer
    Tanios Bekaii‐Saab, Bassel El‐Rayes
    Cancer.2017; 123(8): 1303.     CrossRef
  • Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer
    Shijun Chen, Tianwen Li, Qianfu Zhao, Bingxiu Xiao, Junming Guo
    Clinica Chimica Acta.2017; 466: 167.     CrossRef
  • Screening endoscopy finds high prevalence of Helicobacter pylori and intestinal metaplasia in Korean American with limited access to health care
    Yanghee Woo, Carolyn E. Behrendt, Garrick Trapp, Jae Geun Hyun, Tamas Gonda, Yuman Fong, Timothy Wang
    Journal of Surgical Oncology.2017; 116(2): 172.     CrossRef
  • Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer
    Zhen-Qiang Wang, Qiang Cai, Lei Hu, Chang-Yu He, Jian-Fang Li, Zhi-Wei Quan, Bing-Ya Liu, Chen Li, Zheng-Gang Zhu
    Cell Death & Disease.2017; 8(6): e2839.     CrossRef
  • Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer
    Zhen-qiang Wang, Chang-yu He, Lei Hu, Hong-peng Shi, Jian-fang Li, Qin-long Gu, Li-ping Su, Bing-ya Liu, Chen Li, Zhenggang Zhu
    Cancer Letters.2017; 408: 10.     CrossRef
  • Association of Nutrition Status-Related Indices and XELOX Chemotherapy Compliance in Gastric Cancer Patients
    Sang Hyun Park, Geum Jong Song, Myoung Won Son, Sun Wook Han, Sang Ho Bae, Sung Yong Kim, Moo Jun Baek, Moon Soo Lee
    Surgical Metabolism and Nutrition.2017; 8(2): 36.     CrossRef
  • Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer
    Yao-fei Pei, Ya-jing Zhang, Yao Lei, Ding-wei Wu, Tong-hui Ma, Xi-qiang Liu
    Oncotarget.2017; 8(14): 23155.     CrossRef
  • Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer
    Tao Du, Baogui Zhang, Shun Zhang, Xiaohua Jiang, Ping Zheng, Jianfang Li, Min Yan, Zhenggang Zhu, Bingya Liu
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2016; 1862(1): 12.     CrossRef
  • Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasms
    Wojciech Błogowski, Ewa Zuba-Surma, Daria Sałata, Marta Budkowska, Barbara Dołęgowska, Teresa Starzyńska
    OncoImmunology.2016;[Epub]     CrossRef
  • Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations
    Yi-Chia Lee, Tsung-Hsien Chiang, Jyh-Ming Liou, Hsiu-Hsi Chen, Ming-Shiang Wu, David Y Graham
    Gut and Liver.2016; 10(1): 12.     CrossRef
  • Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection
    Mikitaka Iguchi, Jun Kato, Takeichi Yoshida, Yasuhide Yamamoto, Kenichiro Nakachi, Kazuhiro Fukatsu, Yoshiyuki Mori, Yoshimasa Maeda, Kosaku Moribata, Naoki Shingaki, Toru Niwa, Hisanobu Deguchi, Izumi Inoue, Takao Maekita, Hideyuki Tamai, Masao Ichinose
    International Journal of Cancer.2016; 139(5): 1150.     CrossRef
  • Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study
    Xuefeng Yu, Fulan Hu, Qiang Yao, Chunfeng Li, Hongfeng Zhang, Yingwei Xue
    BMC Cancer.2016;[Epub]     CrossRef
  • MicroRNA Genetic Variation: From Population Analysis to Functional Implications of Three Allele Variants Associated with Cancer
    Ignasi Torruella-Loran, Hafid Laayouni, Begoña Dobon, Alicia Gallego, Ingrid Balcells, Eva Garcia-Ramallo, Yolanda Espinosa-Parrilla
    Human Mutation.2016; 37(10): 1060.     CrossRef
  • DO PROXIMAL AND DISTAL GASTRIC TUMOURS BEHAVE DIFFERENTLY?
    Laurence Bedin da COSTA, Marcelo Garcia TONETO, Luis Fernando MOREIRA
    ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo).2016; 29(4): 232.     CrossRef
  • Recent developments and innovations in gastric cancer
    Mehmet Mihmanli, Enver Ilhan, Ufuk Oguz Idiz, Ali Alemdar, Uygar Demir
    World Journal of Gastroenterology.2016; 22(17): 4307.     CrossRef
  • Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer
    Jia-Xin Shen, Jing Liu, Guan-Wu Li, Yi-Teng Huang, Hua-Tao Wu
    Oncotarget.2016; 7(18): 25340.     CrossRef
  • Etiology and Prevention of Gastric Cancer
    Xiao Jiao Cheng, Jia Cheng Lin, Shui Ping Tu
    Gastrointestinal Tumors.2016; 3(1): 25.     CrossRef
  • xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases
    Lu Dai, Mairi C. Noverr, Chris Parsons, Johnan A. R. Kaleeba, Zhiqiang Qin
    Frontiers in Microbiology.2015;[Epub]     CrossRef
  • Long-term survival trends of gastric cancer patients between 1972 and 2011 in Qidong
    Yong-Sheng Chen, Jian-Guo Chen, Jian Zhu, Yong-Hui Zhang, Lu-Lu Ding
    Chinese Journal of Cancer.2015;[Epub]     CrossRef
  • Treatment for unresectable gastric cancer
    Tae-Yong Kim, Do-Youn Oh, Yung-Jue Bang
    Journal of the Korean Medical Association.2015; 58(3): 209.     CrossRef
  • Evaluation of selected interleukins in patients with different gastric neoplasms: a preliminary report
    Anna Madej-Michniewicz, Marta Budkowska, Daria Sałata, Barbara Dołęgowska, Teresa Starzyńska, Wojciech Błogowski
    Scientific Reports.2015;[Epub]     CrossRef
  • Review on the Applications and Molecular Mechanisms ofXihuangPill in Tumor Treatment
    Qiujun Guo, Jinyin Lin, Rui Liu, Yebo Gao, Shulin He, Xinyao Xu, Baojin Hua, Conghuang Li, Wei Hou, Honggang Zheng, Yanju Bao
    Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
  • The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways
    Yu-yu Gu, Mei Yang, Mei Zhao, Qing Luo, Lin Yang, Hua Peng, Jia Wang, Sheng-kai Huang, Zhao-xu Zheng, Xing-hua Yuan, Ping Liu, Chang-zhi Huang
    Tumor Biology.2015; 36(11): 8379.     CrossRef
  • Farnesoid X receptor signal is involved in deoxycholic acid-induced intestinal metaplasia of normal human gastric epithelial cells
    SHU LI, XIN CHEN, LU ZHOU, BANG-MAO WANG
    Oncology Reports.2015; 34(5): 2674.     CrossRef
  • Emerging blood-based biomarkers for detection of gastric cancer
    Zane Kalniņa
    World Journal of Gastroenterology.2015; 21(41): 11636.     CrossRef
  • Long Survival with Metronomic Therapy for Heavily Pretreated Advanced Gastric Cancer: Case Report
    Boutayeb Saber
    MOJ Clinical & Medical Case Reports.2015;[Epub]     CrossRef
  • 14,343 View
  • 201 Download
  • 113 Web of Science
  • 97 Crossref
Close layer
Focused Review Series: Endoscopic and Molecular Imaging of Premalignant GI Lesions, Part II
Barrett Esophagus: When to Endoscope
Joshua Butt, Gabor Kandel
Clin Endosc 2014;47(1):40-46.   Published online January 24, 2014
DOI: https://doi.org/10.5946/ce.2014.47.1.40
AbstractAbstract PDFPubReaderePub

Increasing interest in identifying an effective strategy for decreasing the burden of esophageal adenocarcinoma (EAC) has been fuelled by the rising EAC rates worldwide, the morbidity associated with esophagectomy, and the development of endoscopic methods for curing early-stage EAC. In the face of this enthusiasm, however, we should be cautious about continuing our current evidence-free approach to screening and one with unclear benefits and unclear costs to the community. The literature is increasingly recognizing that the value of traditional endoscopy for screening and surveillance of Barrett esophagus may be more limited than initially believed. A better understanding of the risk factors for Barrett esophagus and progression to dysplasia and a more individualized risk calculation will be useful in defining populations to consider for Barrett screening. The development of novel, nonendoscopic screening techniques and of less expensive endoscopic techniques holds promise for a cost-effective screening and surveillance method to curtail the increasing rates of EAC.

Citations

Citations to this article as recorded by  
  • The importance of a second opinion in the diagnosis of Barrett’s esophagus: a “real life” study
    Vincenzo Villanacci, Marianna Salemme, Italo Stroppa, Valerio Balassone, Gabrio Bassotti
    Revista Española de Enfermedades Digestivas.2016;[Epub]     CrossRef
  • Diagnostic Accuracy of Mucosal Biopsy versus Endoscopic Mucosal Resection in Barrett’s Esophagus and Related Superficial Lesions
    Hany M. Elsadek, Mamdouh M. Radwan
    International Scholarly Research Notices.2015; 2015: 1.     CrossRef
  • Aneusomy detected by fluorescence in‐situ hybridization has high positive predictive value for Barrett's dysplasia
    Euan A G Allan, Roy Miller, James J Going
    Histopathology.2015; 67(4): 451.     CrossRef
  • Endoscopic surveillance of gastrointestinal premalignant lesions
    Veroushka Ballester, Marcia Cruz-Correa
    Current Opinion in Gastroenterology.2014; 30(5): 477.     CrossRef
  • 8,519 View
  • 51 Download
  • 4 Web of Science
  • 4 Crossref
Close layer
원저 : 식도 위장관 ; 건강검진 수진자 9,137 명에 대한 위내시경적 집단 검진 소견 ( Original Articles : Esophagus , Stomach & Intestine ; Esophgogastroduodenoscopic Findings in 9,137 Healthy Subjects Examined for the Secondary Prevention )
Korean J Gastrointest Endosc 1998;18(2):161-168.   Published online November 30, 1997
AbstractAbstract PDF
Background
A esophagogastroduodenoscopy is now considered to be one of the essential rnethods for diagnosis of upper gastrointestinal disease. Furthermore early detection of stomach cancer by such a mass screening techique is very important to increase the survival rate. Methods: A clinical analysis was conducted on 9,137 healthy subjects who had undergone a gastrofiberscopic examination for the secondary prevention, from January 1995 to December 1996, in Kangbuk Samsung hospital. Results: 1) Number of cases with normal finding was 764 (8.4%). 2) The most prevalent disease found was chronic gastritis (82%). The number of cases with superficial gastritis was 64.7%, erosive gastritis 9.0%, atrophic gastritis 6.4% and metaplastic gastritis 1.6%. Atrophic and metaplastic gastritis were more frequent in the older age group. 3) The prevalence of peptic ulcer was 13.9% and duodenal ulcers (8.1%) was more common than gastric ulcers (5.8%, p<0.05) with a male to female ratio of 3.7: 1, and 2.1: 1 respectively. 4) Of the 10 cases with stomach cancer (0.11%), 5 cases (0.055%) were found to be advanced stomach cancer and the other 5 cases (0.055%) were early gastric cancer. The macroscopic type of early gastric cancer was type IIc in 4 cases and type IIb in another case, and 4 cases were limited in mucosa but another was in submucosa. The size of 4 cases were below 1 cm and there was no lymph node metastasis. Conclusion: Medically screened subjects were found to have many abnormalities, and therefore, it is recommanded that regular check ups using an endoscopy would be needed for early detection of early gastric cancer regardless of clinical symptoms. (Korean J Gastrointest Endosc 18: 161-168, 1998)
  • 1,618 View
  • 12 Download
Close layer
자동차제조회사 근로자 1865명에 대한 위내시경적 집단검진 소견 ( Mass Screening for Stomach Cancer by Gastrofiberscopy in 1865 Employees of a Car Manufacturing Company )
Korean J Gastrointest Endosc 1993;13(2):347-352.   Published online November 30, 1992
AbstractAbstract PDF
Background
Stomach cancer is the most commonly diagnosed malignant tumor in Korea. Early detection by mass screening very important to increase survival rate of stomach cancer, because the prognosis of early gastric cancer is excellent, and specific symptoms and physical findings are rare with early gastric cancer. Methed: 1865 car manufacturing company employees were examinined by gastrofiberscopy at a dispensary of the company from May 6, l992 to July 13, 1992. Results: 1. Number of cases with normal finding was 1262(67.7%), gastritis 422(22.6%), gastric ulcer 47(2.5%), gasrtric cancer 4(0.2%), duodenitis 39(2.1%), duodenal ulcer 63(3.4%), combined ulcer(gastric & duodenal) 2(0.1%,), post operative state 6(0.3%), and others 4(0.3%) in total 1865 examinees. 2. Of 422 cases with gastritis, cases with superficial gastritis were 171 (9.2%), atrophic gastritis 138(7.4%), erosive gastritis 94(5.0%) and hemorrhagic gastritis 19(1.0%). 3. Of 4 cases with stomach cancer, 1 case was advanced stomach cancer and 3 cases were early gastric cancer(two cases of IIc and one case of IIc+III) by macroscopic classification. Conclusion: Mass screening provides an excellent opportunity to detect gastric cancer in populations without symytoms or with nonspecific symptoms. It should be recommended to undergo screening exam for high risk group of stomach cancer.
  • 1,568 View
  • 2 Download
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP